Thus, hyaluronic acid and chitosan-based NPs targeting CD-44 in glioblastoma cells and containing curcumin, which reduces the survival of C6 glioblastoma cells to 75% by itself and to 55% in NPs within 24 h, were obtained in [19]. This evidence concerns the gene CD44 and glioblastoma.